Global Life Science Ventures
Vivo and OrbiMed lead $120m series-B for Nabriva Therapeutics
US investors lead rounds with initial $50m tranche
Forbion et al. sell Santaris Pharma to Roche for $450m
Deal includes $200m in performance-based payouts
Sofinnova leads €15m round for Pixium
Sofinnova Partners has led a €15m extension of Pixium Vision’s two-part series-A round alongside BPI France and existing investors Omnes Capital and Abingworth Management.